Clinical trial
A Phase 3, INterVentional, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of DCC-2618 In Patients With AdvanCed Gastrointestinal Stromal TUmorS Who Have Received Treatment With Prior Anticancer Therapies
NCT03353753 is registered in ClinicalTrials.gov with Deciphera Pharmaceuticals, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, INterVentional, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of DCC-2618 In Patients With AdvanCed Gastrointestinal Stromal TUmorS Who Have Received Treatment With Prior Anticancer Therapies
- Lead sponsor
- Deciphera Pharmaceuticals, LLC
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 27, 2018
- Completion date
- May 11, 2022
- Enrollment
- 129 (actual)
- Sites
- 35
Conditions
As the registry lists them; a condition with its own page is linked.